Alli set to launch chewable tablet this year in Europe

LONDON — GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.

The drug maker said it plans to sell new chewable tablets this spring, available at pharmacies throughout the United Kingdom.

Alli has been available in the United Kingdom since early 2009.

Recommended stories

Login or Register to post a comment.